J Oral Rehabil:白塞病患者 两因素或使病情加重

2018-12-06 杨帆 编译 中国医学论坛报今日口腔

土耳其的一项研究显示,对于白塞病患者而言,口腔内的龋齿情况和拔牙治疗会进一步加重白塞病的病情。因此,改善口腔健康的目的应该是消除微生物因素,后者是致病过程的一个环节。该论文11月22日在线发表于《口腔康复学杂志》(J Oral Rehabil)。


土耳其的一项研究显示,对于白塞病患者而言,口腔内的龋齿情况和拔牙治疗会进一步加重白塞病的病情。因此,改善口腔健康的目的应该是消除微生物因素,后者是致病过程的一个环节。该论文11月22日在线发表于《口腔康复学杂志》(J Oral Rehabil)。

为了研究口腔健康作为感染病灶是否在白塞病(BD)患者的疾病过程中起介导作用,研究者对194例白塞病患者的口腔健康进行了基线和随访期的检查,最后一次牙科检查的原因记录为拔牙或对照组定期随访/按计划治疗。白塞病的疾病严重程度评分是用分数来计算,得分越高表明病情越严重。该研究采用多重中介效应分析的方法,评估口腔健康状况对随访期疾病严重程度评分的影响。

结果为,随访时龋齿和牙周指数均高于基线水平(P<0.05)。疾病严重程度评分男性(5.3±2.4)高于女性(4.4±2.5),结果具有显著性差异(P0.005)。最后一次就诊时拔牙的患者和龋病患者的病程(5.4±2.4;5.5±2.5)较其他患者(4.2±2.3;4.4±2.4)更为严重(P<0.0001)。在多因素分析中,疾病严重程度评分是一个因变量,与男性性别直接相关(B=-0.8822,P=0.0145),并且间接作用于龋病的存在(B=0.9509,P=0.0110)和拔牙需求(B0.8758,P=0.0128)。

原始出处:

Yay M,et al.Oral health is a mediator for disease severity in patients with behcet's disease: a multiple mediation analysis study.J Oral Rehabil. 2018 Nov 22. doi: 10.1111/joor.12750. [Epub ahead of print]         

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1799549, encodeId=74c11e99549b7, content=<a href='/topic/show?id=e98ee086708' target=_blank style='color:#2F92EE;'>#病情加重#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70867, encryptionId=e98ee086708, topicName=病情加重)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Apr 14 12:15:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020517, encodeId=d046202051e21, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sat Dec 22 20:15:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765064, encodeId=c1de1e650645d, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jun 26 06:15:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521917, encodeId=3d58152191ebd, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 08 02:15:00 CST 2018, time=2018-12-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1799549, encodeId=74c11e99549b7, content=<a href='/topic/show?id=e98ee086708' target=_blank style='color:#2F92EE;'>#病情加重#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70867, encryptionId=e98ee086708, topicName=病情加重)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Apr 14 12:15:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020517, encodeId=d046202051e21, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sat Dec 22 20:15:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765064, encodeId=c1de1e650645d, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jun 26 06:15:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521917, encodeId=3d58152191ebd, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 08 02:15:00 CST 2018, time=2018-12-08, status=1, ipAttribution=)]
    2018-12-22 小几洁
  3. [GetPortalCommentsPageByObjectIdResponse(id=1799549, encodeId=74c11e99549b7, content=<a href='/topic/show?id=e98ee086708' target=_blank style='color:#2F92EE;'>#病情加重#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70867, encryptionId=e98ee086708, topicName=病情加重)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Apr 14 12:15:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020517, encodeId=d046202051e21, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sat Dec 22 20:15:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765064, encodeId=c1de1e650645d, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jun 26 06:15:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521917, encodeId=3d58152191ebd, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 08 02:15:00 CST 2018, time=2018-12-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1799549, encodeId=74c11e99549b7, content=<a href='/topic/show?id=e98ee086708' target=_blank style='color:#2F92EE;'>#病情加重#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70867, encryptionId=e98ee086708, topicName=病情加重)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Apr 14 12:15:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020517, encodeId=d046202051e21, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sat Dec 22 20:15:00 CST 2018, time=2018-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765064, encodeId=c1de1e650645d, content=<a href='/topic/show?id=df00e086653' target=_blank style='color:#2F92EE;'>#病情#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70866, encryptionId=df00e086653, topicName=病情)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Jun 26 06:15:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521917, encodeId=3d58152191ebd, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 08 02:15:00 CST 2018, time=2018-12-08, status=1, ipAttribution=)]
    2018-12-08 qjddjq

相关资讯

2018 EULAR建议:白塞氏综合征的管理(更新版)

2018年4月,欧洲抗风湿病联盟(EULAR)更新发布了白塞氏综合征的管理建议,是对2008年发布的第一版白塞病管理建议的更新,本文的主要目的是更新和改善白塞氏综合征的管理建议,主要建议内容包括白塞氏综合征皮肤黏膜,关节,眼,血管,神经以及胃肠症状的管理。

Oncotarget:GATA3,IL-4和TGF-β的高甲基化与白塞病风险相关

白塞病(Betch's disease,BD)又称丝绸之路病,因为这一疾病在日本、中国、土耳其、伊朗等地的发病率较高,发病范围与古代丝绸之路的线路基本吻合。BD是一种全身慢性疾病,是一原因不明的细小血管炎为病理基础的慢性、进行性复发性、多系统损害的疾病。

您听说过“神经白塞病”吗?

男44岁,曾有过上呼吸道感染,之后出现四肢无力,并且曾反复多次出现口腔溃疡、毛囊炎,后又出现外阴溃疡、皮疹。对于患者出现的上述症状,医生是如何诊断的呢?又给予了怎样的治疗呢?

具有消化系统表现的白塞病的临床特点

白塞病(Behcet’s disease,BD)是一种慢性全身性血管炎症性疾病,主要表现为复发性口腔溃疡、生殖器溃疡、眼炎及皮肤损害,也可累及血管、神经系统、消化道、关节、肺、肾、附睾等器官。本病在东亚、中东和地中海地区发病率较高,好发年龄为16~40岁。白塞病的消化道损害又称肠白塞(intestial Behcet’s disease),发病率在4%~50%,临床上常需与炎症性肠病、肠结核等

白塞病并发颅内静脉血栓形成一例

  临床资料    患者男,27岁,系头痛2个月伴双下肢无力1个月余于2011年12月19日入院。   患者于2010年11月突发右下肢肿痛在浙江某医院行B超检查,显示下肢静脉血栓形成,病因不明。2011年3月患者出现左下肢肿痛,在某市立医院行下肢静脉造影,结果显示左下肢深静脉血栓形成,予以华法林口服。2011年11月患者自觉头痛不适,双侧颞部呈持续性胀痛伴有视物模糊,12月